1

(R)-7-(benzyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione (1985607-70-2) (R)-7-(benzyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione serves as a key intermediate in the synthesis of Baloxavir marboxil, primarily utilized in laboratory research and industrial production processes. Product Specifications Product Name: (R)-7-(benzyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1

Semaglutide 99% (Sterile) Injection Grade (910463-68-2) Semaglutide (CAS 910463-68-2) is an anti-diabetic medication used for the treatment of type 2 diabetes and chronic weight management. Semaglutide (Sterile) 99% is specifically prepared for the formulation of Semaglutide injection. This product achieves a purity level of 99.0% with an assay range of 95%~105% and peptide content of Semaglutide between 76%~100%. Product Specifications Product Name: Semaglutide primary

Semaglutide 98% (Oral Grade) (910463-68-2) Semaglutide (CAS 910463-68-2) is an anti-diabetic medication used for the treatment of type 2 diabetes and chronic weight management. Semaglutide for oral grade 98% is specifically formulated for markets requiring high standards in oral dosage forms with strict control of raw material impurities. This product maintains a purity level of 98% while meeting the same acceptance criteria as Semaglutide injectable grade 99%. Product

Semaglutide 96% (Oral Grade) (910463-68-2) Semaglutide (CAS 910463-68-2) is an anti-diabetic medication used for the treatment of type 2 diabetes and chronic weight management. Semaglutide Oral Grade 96% is specifically formulated for price-sensitive markets where the tabbing process does not introduce new impurities. This product maintains a purity level of 96% with an assay range of 90% to 100%. Product Specifications Product Name Semaglutide 96% (Oral Grade) CAS Number

6-Bromomethyl-3,4-dihydro-2-methyl-quinazolin-4-one (112888-43-4) 6-Bromomethyl-3,4-dihydro-2-methyl-quinazolin-4-one is a key intermediate used in the synthesis of Raltitrexed, an important pharmaceutical compound. Product Specifications Product Name: 6-Bromomethyl-3,4-dihydro-2-methyl-quinazolin-4-one CAS No.: 112888-43-4 Assay: 98% End Use: Raltitrexed Intermediate Molecular Formula: C10 H9 BrN2 O Molecular Weight: 253.1 Shelf Life: 2 Years Package: 25kg/drum Product

Octadecanedioic Acid Mono-tert Butyl Ester (843666-40-0) Octadecanedioic acid mono-tert butyl ester serves as a key intermediate in the synthesis of Semaglutide, specifically forming the side chain end of this important pharmaceutical compound. Product Specifications Product Name: Octadecanedioic acid mono-tert butyl ester CAS No.: 843666-40-0 Assay: 98% End Use: Semaglutide Molecular Formula: C22 H42 O4 Molecular Weight: 370.57 Shelf Life: 2 Years Package: Vial or LDPE

Semaglutide Main Chain P29 (N-3) - 1169630-82-3 Semaglutide main chain P29 and Semaglutide side chain (tetrapeptide) are key intermediates in the synthesis of Semaglutide API. The Semaglutide main chain P29 undergoes acylation with the Semaglutide side chain to form the primary acylation intermediate, which is further processed to obtain the final active pharmaceutical ingredient. These high-purity intermediates are specifically designed for pharmaceutical enterprises with

Fmoc-His-Aib-OH (N-2 Fragment Intermediate) Code: Fmoc-His-Aib-OH (N-2 fragment intermediate) (1446013-07-5) Product Overview This Semaglutide primary acylation intermediate and Semaglutide dipeptide serve as key building blocks in Semaglutide synthesis. The N-2 fragment intermediate undergoes acylation with Semaglutide dipeptide to form the secondary acylation intermediate, which is subsequently hydrolyzed to yield Semaglutide crude product. The manufacturing process

Boc-L-His(Boc)-Aib-OH (N-2 Fragment Intermediate) Product Code: 2765344-17-8 This Semaglutide primary acylation intermediate and Semaglutide dipeptide serve as crucial N-2 main chain intermediate and N-2 fragment components in Semaglutide synthesis. The primary acylation intermediate undergoes acylation with Semaglutide dipeptide to produce the Semaglutide secondary acylation intermediate, which is subsequently hydrolyzed to yield the Semaglutide crude product. Required